CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 75 of 276 entries

View as:

Project ICARE: Intervening for Community Awareness, Respect, & Empowerment

Phase: N/A Priority: Normal

NCT ID: NCT00712088 Org: User:

Start: 07/31/08 End: 03/31/10 Due: 03/31/11

Comparison of Facility and Home-based ART Delivery Systems in Uganda

Phase: N/A Priority: Normal

NCT ID: NCT00144365 Org: User:

Start: 02/28/05 End: 12/31/10 Due: 12/31/11

The California WISEWOMAN Project:Cardiovascular(CVD) Health for Hispanic Women

Phase: N/A Priority: Normal

NCT ID: NCT00153400 Org: User:

Start: 01/31/06 End: 06/30/07 Due: 06/30/08

Promoting Colorectal Cancer Screening in Rural Colorado

Phase: N/A Priority: Normal

NCT ID: NCT00137592 Org: User:

Start: 10/31/05 End: 12/31/08 Due: 12/31/09

Fetal Alcohol Syndrome/ARND Research Consortion

Phase: N/A Priority: Normal

NCT ID: NCT00164554 Org: User:

Start: 10/31/01 End: 06/30/05 Due: 06/30/06

Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, Brazil

Phase: N/A Priority: Normal

NCT ID: NCT02043652 Org: User:

Start: 02/28/14 End: 12/31/14 Due: 12/31/15

Evaluation of an Intervention to Increase Colorectal Cancer Screening in Primary Care Clinics

Phase: N/A Priority: Normal

NCT ID: NCT00737646 Org: User:

Start: 07/31/09 End: 12/31/11 Due: 12/31/12

Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness

Phase: N/A Priority: Normal

NCT ID: NCT00127504 Org: User:

Start: 07/31/03 End: 05/31/04 Due: 05/31/05

Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men

Phase: N/A Priority: Normal

NCT ID: NCT00131677 Org: User:

Start: 02/28/05 End: 08/31/09 Due: 08/31/10

Utilization of the Community Popular Opinion Leader (C-POL) Model in Alabama

Phase: N/A Priority: Normal

NCT ID: NCT00260754 Org: User:

Start: 10/31/02 End: 07/31/05 Due: 07/31/06

Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana

Phase: N/A Priority: Normal

NCT ID: NCT00164281 Org: User:

Start: 11/30/04 End: 05/31/11 Due: 05/31/12

Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis

Phase: N/A Priority: Normal

NCT ID: NCT02563327 Org: User:

Start: 05/30/16 End: 03/31/20 Due: 03/31/21

TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens

Phase: N/A Priority: Normal

NCT ID: NCT02410772 Org: User:

Start: 01/25/16 End: 05/31/21 Due: 05/31/22

Impact on Linkage to HIV Care With Point of Care CD4 Testing and Home-based HIV Testing in Kenya

Phase: N/A Priority: Normal

NCT ID: NCT02515149 Org: User:

Start: 07/31/13 End: 12/31/14 Due: 12/31/15

University of Oklahoma Parenting Program Attrition

Phase: N/A Priority: Normal

NCT ID: NCT00153465 Org: User:

Start: 01/31/04 End: 09/30/06 Due: 09/30/07

Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya

Phase: N/A Priority: Normal

NCT ID: NCT01810731 Org: User:

Start: 04/30/14 End: 04/30/14 Due: 04/30/15

Tuberculosis Clinical Trials Consortium Study 35

Phase: N/A Priority: Normal

NCT ID: NCT03730181 Org: User:

Start: 10/12/19 End: 05/15/25 Due: 05/15/26

Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis

Phase: N/A Priority: Normal

NCT ID: NCT01622140 Org: User:

Start: 10/31/12 End: 12/31/20 Due: 12/31/21

A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A

Phase: N/A Priority: Normal

NCT ID: NCT00139139 Org: User:

Start: 09/30/03 End: 05/31/05 Due: 05/31/06

Botswana Tenofovir Oral HIV Prophylaxis Trial

Phase: N/A Priority: Normal

NCT ID: NCT00111150 Org: User:

Start: 09/30/05 End: 03/31/07 Due: 03/31/08

TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment

Phase: N/A Priority: Normal

NCT ID: NCT00694629 Org: User:

Start: 12/31/08 End: 12/31/13 Due: 12/31/14

TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis

Phase: N/A Priority: Normal

NCT ID: NCT00023335 Org: User:

Start: 04/30/95 End: 03/31/01 Due: 03/31/02

Pennsylvania Abusive Head Trauma Prevention Program

Phase: N/A Priority: Normal

NCT ID: NCT00727116 Org: User:

Start: 01/31/08 End: 09/30/12 Due: 09/30/13

Study to Improve Partner Services for STD Prevention

Phase: N/A Priority: Normal

NCT ID: NCT00207467 Org: User:

Start: 12/31/01 End: 12/31/04 Due: 12/31/05

Iowa WISEWOMAN Project

Phase: N/A Priority: Normal

NCT ID: NCT00153374 Org: User:

Start: - End: - Due: -

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Project ICARE: Intervening for Community Awareness, Respect, & Empowerment	NCT00712088	Centers for Disease Control and Prevention	user2@example.com	None	2008-07-31	2010-03-31	2011-03-31	-	-	2025-07-14
Comparison of Facility and Home-based ART Delivery Systems in Uganda	NCT00144365	Centers for Disease Control and Prevention	user2@example.com	None	2005-02-28	2010-12-31	2011-12-31	-	-	2025-07-14
The California WISEWOMAN Project:Cardiovascular(CVD) Health for Hispanic Women	NCT00153400	Centers for Disease Control and Prevention	user2@example.com	None	2006-01-31	2007-06-30	2008-06-30	-	-	2025-07-14
Promoting Colorectal Cancer Screening in Rural Colorado	NCT00137592	Centers for Disease Control and Prevention	user2@example.com	None	2005-10-31	2008-12-31	2009-12-31	-	-	2025-07-14
Fetal Alcohol Syndrome/ARND Research Consortion	NCT00164554	Centers for Disease Control and Prevention	user2@example.com	None	2001-10-31	2005-06-30	2006-06-30	-	-	2025-07-14
Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, Brazil	NCT02043652	Centers for Disease Control and Prevention	user2@example.com	None	2014-02-28	2014-12-31	2015-12-31	-	-	2025-07-14
Evaluation of an Intervention to Increase Colorectal Cancer Screening in Primary Care Clinics	NCT00737646	Centers for Disease Control and Prevention	user2@example.com	None	2009-07-31	2011-12-31	2012-12-31	-	-	2025-07-14
Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness	NCT00127504	Centers for Disease Control and Prevention	user2@example.com	None	2003-07-31	2004-05-31	2005-05-31	-	-	2025-07-14
Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men	NCT00131677	Centers for Disease Control and Prevention	user2@example.com	None	2005-02-28	2009-08-31	2010-08-31	-	-	2025-07-14
Utilization of the Community Popular Opinion Leader (C-POL) Model in Alabama	NCT00260754	Centers for Disease Control and Prevention	user2@example.com	None	2002-10-31	2005-07-31	2006-07-31	-	-	2025-07-14
Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana	NCT00164281	Centers for Disease Control and Prevention	user2@example.com	None	2004-11-30	2011-05-31	2012-05-31	-	-	2025-07-14
Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis	NCT02563327	Centers for Disease Control and Prevention	user2@example.com	None	2016-05-30	2020-03-31	2021-03-31	-	-	2025-07-14
TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens	NCT02410772	Centers for Disease Control and Prevention	user2@example.com	None	2016-01-25	2021-05-31	2022-05-31	-	-	2025-07-14
Impact on Linkage to HIV Care With Point of Care CD4 Testing and Home-based HIV Testing in Kenya	NCT02515149	Centers for Disease Control and Prevention	user2@example.com	None	2013-07-31	2014-12-31	2015-12-31	-	-	2025-07-14
University of Oklahoma Parenting Program Attrition	NCT00153465	Centers for Disease Control and Prevention	user2@example.com	None	2004-01-31	2006-09-30	2007-09-30	-	-	2025-07-14
Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya	NCT01810731	Centers for Disease Control and Prevention	user2@example.com	None	2014-04-30	2014-04-30	2015-04-30	-	-	2025-07-14
Tuberculosis Clinical Trials Consortium Study 35	NCT03730181	Centers for Disease Control and Prevention	user2@example.com	None	2019-10-12	2025-05-15	2026-05-15	-	-	2025-07-14
Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis	NCT01622140	Centers for Disease Control and Prevention	user2@example.com	None	2012-10-31	2020-12-31	2021-12-31	-	-	2025-07-14
A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A	NCT00139139	Centers for Disease Control and Prevention	user2@example.com	None	2003-09-30	2005-05-31	2006-05-31	-	-	2025-07-14
Botswana Tenofovir Oral HIV Prophylaxis Trial	NCT00111150	Centers for Disease Control and Prevention	user2@example.com	None	2005-09-30	2007-03-31	2008-03-31	-	-	2025-07-14
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment	NCT00694629	Centers for Disease Control and Prevention	user2@example.com	None	2008-12-31	2013-12-31	2014-12-31	-	-	2025-07-14
TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis	NCT00023335	Centers for Disease Control and Prevention	user2@example.com	None	1995-04-30	2001-03-31	2002-03-31	-	-	2025-07-14
Pennsylvania Abusive Head Trauma Prevention Program	NCT00727116	Centers for Disease Control and Prevention	user2@example.com	None	2008-01-31	2012-09-30	2013-09-30	-	-	2025-07-14
Study to Improve Partner Services for STD Prevention	NCT00207467	Centers for Disease Control and Prevention	user2@example.com	None	2001-12-31	2004-12-31	2005-12-31	-	-	2025-07-14
Iowa WISEWOMAN Project	NCT00153374	Centers for Disease Control and Prevention	user2@example.com	None	-	-	-	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance